KLK3 and prostate carcinoma: Holothurin A suppresses the growth of androgen-sensitive prostate cancer cells by reducing AR and PSA activity; molecular docking simulations reveal that it forms hydrophobic interactions with valine 676, isoleucine 680, and alanine 721 within the ligand-binding domain of AR, forming a stable complex [43].